drugset / Trial / NCT02046031
Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.
Phase 4
Completed
4 enrolled
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
To explore the rule of absorption, distribution, metabolism and elimination after intravenous administration of Ginkgolides Meglumine Injection healthy subjects. The plasma drug profiles will be important to assess the potential clinical drug-drug interactions.
Timeline
- Start
- 2014-02
- Primary completion
- 2014-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ginkgolides Meglumine Injection | Unknown | 25 mg | Intravenous |